Numbers have always haunted the AIDS community: skyrocketing numbers of people with HIV/AIDS, free-falling numbers of T-cells, inexorably rising viral load counts. Protease inhibitors have brought a measure of relief, and more numbers: thousands of experimental drug and dosage combinations being taken by hundreds of thousands of patients.